Epigenetics and Cancer: Mechanisms and Aberrant Reprogramming

This presentation explores the role of epigenetics in cancer, including DNA methylation, histone modification, nucleosome positioning, and micro-RNAs. It discusses the aberrant reprogramming of the epigenome in cancer, including changes in histone modifications and DNA methylation abnormalities. The presentation also covers epigenetic switching in cancer and its impact on tumorigenesis.